MPR delivers practical, up-to-date drug information to healthcare professionals. Using the expertise gained from 25 years of providing point-of-care drug tools, MPR has now created a drug review course exclusively for See below for a list of each quarter's courses. Click here to visit MPR's website.

Latest Courses

Clinical Review

New-Drug Review from MPR (April 2014)

1.00 Credits

MPR Drug News

First Generic Version of Crestor Gets Approval

The Food and Drug Administration (FDA) has approved Watson's Rosuvastatin Calcium Tablets, the first generic version of AstraZeneca's Crestor.

Humulin R U-500 KwikPen Now Available

Eli Lilly announced the launch of Humulin R U-500 KwikPen (insulin human injection), a prefilled device containing a highly concentrated formulation of insulin.

CDC Says Prioritize Use of Antibiotic for Syphilis After Shortage Announced

All products are currently on backorder, which is expected to resolve by July 2016.

Gadavist Approved for Use with MRA of the Supra-Aortic Arteries

Bayer announced that the Food and Drug Administration (FDA) has approved Gadavist (gadobutrol) injection for use with magnetic resonance angiography (MRA) to evaluate known or suspected supra-aortic or renal artery disease in adult and pediatric patients, including term neonates.

FDA to Discuss Mandatory Safety Training for Opioid Prescribers

Experts from the FDA Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee will meet in May.